<DOC>
	<DOCNO>NCT01455181</DOCNO>
	<brief_summary>This study design evaluate effect 6-months treatment NPSP558 reducing requirement supplemental oral calcium active vitamin D , maintain stable total serum calcium level adult subject hypoparathyroidism .</brief_summary>
	<brief_title>A Study Investigate Safety Tolerability NPSP558 , Treatment Adults With Hypoparathyroidism - A Clinical Extension Study Hungary</brief_title>
	<detailed_description>Subjects either must previously complete NPSP558 Study CL1-11-040 ( REPLACE ) include 24 week active therapy 4 week follow-up Week 28 prior enrol study enrol REPLACE drop optimization , currently meet inclusion/exclusion criterion REPLACE .</detailed_description>
	<mesh_term>Hypoparathyroidism</mesh_term>
	<criteria>Patients meet follow inclusion criterion enrol study : 1 . Signed date informed consent form ( ICF ) studyrelated procedure perform 2 . Previously complete 24 week therapy 4 week followup REPLACE study , OR Enrolled REPLACE drop optimization , currently meet inclusion/exclusion criterion REPLACE 3 . Able perform daily SC selfinjections study medication ( designee perform injection ) via multidose injection pen thigh 4 . Willingness ability understand comply protocol 5 . Women : ( 1 ) postmenopausal define 12 month amenorrhea appropriate serum follicle stimulate hormone ( FSH ) level ( &gt; 40 IU/L ) ; ( 2 ) surgically sterilize ; OR ( 3 ) childbearing potential negative pregnancy test screen consent use two acceptable method contraception duration study , pregnancy test every scheduled visit treatment period . Female partner ( childbearing potential ) male study patient must also use acceptable form contraception partner 's participation Patients meet follow exclusion criterion baseline ( Visit 1 ) eligible enrollment study : 1 . Any condition , investigator 's opinion consultation sponsor , would preclude safe use NPSP558 2 . Any disease condition opinion investigator high probability preclude patient complete study patient appropriately comply study requirement 3 . Pregnant lactate woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Hypoparathyroidism</keyword>
	<keyword>NPSP558</keyword>
	<keyword>Parathyroid Hormone 1-84</keyword>
	<keyword>PTH 1-84</keyword>
</DOC>